4 results on '"Yossepowitch, Ofer"'
Search Results
2. Diagnostic Needle Biopsies in Renal Masses: Patient and Physician Perspectives.
- Author
-
Golan S, Lotan P, Tapiero S, Baniel J, Nadu A, and Yossepowitch O
- Subjects
- Adult, Aged, Anxiety, Biopsy, Needle standards, Clinical Decision-Making, Female, Humans, Interviews as Topic, Israel epidemiology, Kidney Neoplasms epidemiology, Male, Middle Aged, Patients psychology, Risk Assessment, Urologists statistics & numerical data, Watchful Waiting methods, Biopsy, Needle methods, Kidney Neoplasms pathology, Kidney Neoplasms surgery, Patients statistics & numerical data, Physicians statistics & numerical data
- Abstract
Background: The utility of renal mass biopsies (RMB) in the diagnosis of kidney tumors remains debatable., Objective: To assess patient and urologist preferences regarding the utilization of RMB., Design, Setting, and Participants: Seventy-three patients diagnosed with renal tumors and 59 board-certified urologists were asked to participate in an interview-based study., Outcome Measurements and Statistical Analysis: Using the standard gamble method we determined the minimal accepted accuracy at which RMB would be favored as part of the diagnostic process. Clinical and demographic data with potential to affect participants' preferences were analyzed., Results and Limitations: At the time of the study interview, 56 patients (77%) were referred for kidney surgery and 17 (23%) opted for surveillance. Overall, 59% of the patients accepted some level of inaccuracy (1-20%), whereas 27% refuted a biopsy. Anxiety associated with the possibility of missing cancer was the primary determinant (82%) for declining RMB among patients referred for surgery, while fear of complications was the primary reason (58%) among those undergoing surveillance. Having an academic degree was associated with a lower accuracy threshold (p=0.03). Of the 59 participating urologists, 39% were reluctant to recommend RMB, primarily because of its inexorable nondiagnostic rate., Conclusions: Most patients and urologists would favor RMB to facilitate their definitive treatment decision. Diagnostic accuracy of 95% was acceptable by the majority of study participants. The utility of RMB as part of the diagnostic algorithm for renal tumors should be discussed with patients, emphasizing its potential benefits and limitations., Patient Summary: Although needle biopsy seems to be an effective tool to differentiate benign from malignant kidney lesions, it is not commonly used. Our study shows that most patients would opt for a biopsy before definitive treatment decision despite its imperfect accuracy. Hence, the option of undergoing renal biopsy should be discussed with all patients diagnosed with small renal tumors., (Copyright © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
3. Radiation therapy for prostate cancer increases the risk of subsequent rectal cancer.
- Author
-
Margel D, Baniel J, Wasserberg N, Bar-Chana M, and Yossepowitch O
- Subjects
- Aged, Cause of Death, Cohort Studies, Cross-Sectional Studies, Humans, Incidence, Israel, Kaplan-Meier Estimate, Male, Middle Aged, Neoplasm Staging, Neoplasms, Radiation-Induced mortality, Neoplasms, Radiation-Induced pathology, Neoplasms, Second Primary mortality, Neoplasms, Second Primary pathology, Prognosis, Prostatectomy, Prostatic Neoplasms mortality, Prostatic Neoplasms pathology, Prostatic Neoplasms surgery, Rectal Neoplasms mortality, Rectal Neoplasms pathology, Registries, Risk, Neoplasms, Radiation-Induced etiology, Neoplasms, Second Primary etiology, Prostatic Neoplasms etiology, Prostatic Neoplasms radiotherapy, Rectal Neoplasms etiology
- Abstract
Purpose: To assess whether radiation therapy for prostate cancer (PCa) increases the risk of metachronous rectal cancer (RCa) and compare outcomes of RCa after radiation therapy and surgery., Patients and Methods: The Israel Cancer Registry was queried to identify patients with PCa and RCa diagnosed between 1982 and 2005. The age adjusted standardized incidence ratio (SIR) of RCa was defined as the ratio between the observed and expected (calculated) RCa cases and compared among the following: overall Israeli male population, patients with PCa treated with radiation therapy, patients with PCa treated surgically. The medical records of men diagnosed with RCa were reviewed and clinical characteristics retrieved., Results: Of 29,593 men diagnosed with PCa, 2163 were treated with radiation therapy, 6762 were treated surgically and 20,068 patients were treated with either primary androgen deprivation therapy or offered watchful waiting. Of the entire study cohort, 194 (0.65%) patients were diagnosed with subsequent RCa. Compared to the overall male population and stratified by treatment modality, the risk of developing RCa after radiation therapy was significantly increased (SIR = 1.81, 95% CI 1.2-2.5), whereas it was not increased in those managed by surgery (SIR = 1.22, 95% CI 0.85-1.65). RCa after radiation therapy was diagnosed at a more advanced stage, translating into inferior disease specific survival., Conclusions: Compared to men diagnosed with PCa managed by surgery, we observed an increased risk of RCa in patients treated with radiation therapy. Further studies are needed to validate these findings and assess whether routine colonoscopic surveillance is warranted after pelvic radiation.
- Published
- 2011
- Full Text
- View/download PDF
4. Stress proteins and cytokines are urinary biomarkers for diagnosis and staging of bladder cancer.
- Author
-
Margel D, Pevsner-Fischer M, Baniel J, Yossepowitch O, and Cohen IR
- Subjects
- Aged, Aged, 80 and over, Analysis of Variance, Case-Control Studies, Chaperonin 60 urine, Enzyme-Linked Immunosorbent Assay, Female, Humans, Interleukin-13 urine, Israel, Logistic Models, Male, Middle Aged, Neoplasm Invasiveness, Neoplasm Staging, Odds Ratio, Predictive Value of Tests, ROC Curve, Reproducibility of Results, Urinary Bladder Neoplasms pathology, Urinary Bladder Neoplasms urine, Biomarkers, Tumor urine, Cytokines urine, Heat-Shock Proteins urine, Urinary Bladder Neoplasms diagnosis
- Abstract
Background: Cancer often involves inflammatory processes. We hypothesized that immune mediators in urine may serve as biomarkers for bladder cancer (BCa)., Objective: To investigate whether BCa might be marked by urinary levels of heat shock proteins (HSPs; HSP60, HSP70, or HSP90) or cytokines (interferon [IFN]-γ, tumor necrosis factor [TNF]-α, tumor growth factor [TGF]-β, interleukin [IL]-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, or IL-13)., Design, Setting, and Participants: This was a case-control study with a discovery and validation phase. We examined urine from 106 consecutive patients: healthy controls (n=18); hematuria with no evidence of BCa (n=20); non-muscle-invasive BCa (n=50); and muscle-invasive BCa (n=18). The concentrations of HSPs and cytokines were assessed by enzyme-linked immunosorbent assay. In the validation phase, independent urine samples from 40 patients were analyzed (controls [n=19] and BCa [n=21])., Measurements: We used the area under the curve (AUC) of a receiver operating characteristic analysis to determine the ability of HSPs and cytokines to mark BCa and applied a multivariate logistic regression to create a formula able to diagnose BCa. The formula was applied to the validation set without recalculation, and positive and negative predictive values were calculated., Results and Limitations: Urinary concentrations of IL-8, IL-10, and IL-13 were significantly elevated in BCa; IL-13 was the most prominent marker (AUC: 0.93; 95% confidence interval [CI], 0.85-0.99). The multivariate regression analysis highlighted HSP60 (odds ratio [OR]: 1.206; 95% CI, 1.041-1.397, p=0.003) and IL-13 (OR: 1.020; 95% CI: 1.007-1.033, p=0.012). The validation assay was performed using HSP60 and IL-13. The overall positive predictive value was 74% (95% CI, 64-84%); and the negative predictive value was 76% (95% CI, 66-86%). Since we examined a small number of patients, the results need to be confirmed in a larger cohort., Conclusions: These results suggest that it might be possible to develop a urinary biomarker for BCa and raise the possibility that expression of anti-inflammatory cytokines and HSPs might allow BCa to evade immune surveillance., (Copyright © 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.